Gabapentin Capsules Supply

This subcontract involves the supply of FDA-regulated Gabapentin Capsules (100 MG) to support prime contractors on Department of Defense medical supply chain projects. The scope of work requires the manufacture or procurement of ten bottles of capsules that strictly adhere to FDA regulations and USP Controlled Room Temperature standards of 25 degrees Celsius. To maintain a non-extendable shelf life of 36 months, all products must be handled in FDA-approved facilities and transported using climate-monitored shipping containers. The contract is managed by the Medical Supply Chain Pharm FSA and requires full compliance with the Buy American Act. Performance will take place in Washington, DC, under NAICS code 325412. Interested parties must note the response deadline of November 16, 2026, to ensure all regulatory and delivery specifications are met for this pharmaceutical procurement.